Parallel Advisors, LLC - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V116. A total of 14 filers reported holding EFFECTOR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,877
-44.5%
64,1660.0%0.00%
Q2 2023$8,791
+82.7%
64,1660.0%0.00%
Q1 2023$4,812
-3.2%
64,1660.0%0.00%
Q4 2022$4,973
-61.7%
64,1660.0%0.00%
-100.0%
Q3 2022$13,0000.0%64,1660.0%0.00%0.0%
Q2 2022$13,000
-43.5%
64,166
+20.3%
0.00%0.0%
Q1 2022$23,000
+666.7%
53,333
+1500.2%
0.00%
Q4 2021$3,0003,3330.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Integrity Capital Management (HK) Ltd 66,181$58,0000.18%
ARISTEIA CAPITAL, L.L.C. 1,731,946$1,541,0000.03%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 419,478$369,0000.01%
MMCAP International Inc. SPC 145,941$128,0000.01%
WHITEBOX ADVISORS LLC 298,145$262,0000.01%
CVI Holdings, LLC 88,462$78,0000.01%
LITTLEJOHN & CO LLC 16,666$15,0000.00%
EQUITEC PROPRIETARY MARKETS, LLC 37,700$33,0000.00%
PURA VIDA INVESTMENTS, LLC 100,541$88,0000.00%
III Capital Management 25,900$23,0000.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders